p38/SAPK2 controls gap junction closure in astrocytes

GLIA

Volumn 46, Issue 3, 2004, Pages 323-333

  Zvalova, Darina ^a,b   Cordier, Jocelyne ^a   Mesnil, Marc ^a,c   Junier, Marie Pierre ^a   Chneiweiss, Hervé ^a  

^a INSERM   (France)

^b Cardiovascular and Urology CEDD Medicines Research Centre   (United Kingdom)

^c UNIVERSITÉ DE POITIERS   (France)

Author keywords

Interleukin 1 ; Nucleo cytoplasmic translocation; Osmotic stress; Protein kinase C

Indexed keywords

CONNEXIN 43; IMIDAZOLE DERIVATIVE; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE C; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; INTERLEUKIN 1; MITOGEN ACTIVATED PROTEIN KINASE; SORBITOL;

ANIMAL CELL; ANOXIA; ARTICLE; ASTROCYTE; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM; CHANNEL GATING; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; GAP JUNCTION; IMMUNOCYTOCHEMISTRY; MEDIATOR RELEASE; MOUSE; NERVOUS SYSTEM INJURY; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; OSMOTIC STRESS; PRIORITY JOURNAL; ANIMAL; CELL CULTURE; CELL JUNCTION; COMPARATIVE STUDY; DRUG EFFECT; ENZYMOLOGY; METABOLISM;

ANIMALS; ASTROCYTES; CELLS, CULTURED; GAP JUNCTIONS; INTERLEUKIN-1; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SORBITOL;

EID: 2342646582     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.10334     Document Type: Article

References (52)

1. Araujo H, Danziger N, Cordier J, Glowinski J, Chneiweiss H. 1993. Characterization of PEA-15, a major substrate for protein kinase C in astrocytes. J Biol Chem 268:5911-5920.
2. Barone FC, Irving EA, Ray AM, Lee JC, Kassis S, Kumar S, Badger AM, Legos JJ, Erhardt JA, Ohlstein EH, Hunter AJ, Harrison DC, Philpott K, Smith BR, Adams JL, Parsons AA. 2001a. Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia. Med Res Rev 21:129-145.
3. Barone FC, Irving EA, Ray AM, Lee JC, Kassis S, Kumar S, Badger AM, White RF, McVey MJ, Legos JJ, Erhardt JA, Nelson AH, Ohlstein EH, Hunter AJ, Ward K, Smith BR, Adams JL, Parsons AA. 2001b. SB239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. J Pharmacol Exp Ther 296:312-321.
4. Ben-Levy R, Hooper S, Wilson R, Paterson HF, Marshall CJ. 1998. Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2. Curr Biol 8:1049-1057.
5. Beyer EC, Paul DL, Goodenough DA. 1987. Connexin43: a protein from rat heart homologous to a gap junction protein from liver. J Cell Biol 105:2621-2629.
6. 2+ signaling. Am J Physiol 277:C616-627.
7. Bode JG, Gatsios P, Ludwig S, Rapp UR, Haussinger D, Heinrich PC, Graeve L. 1999. The mitogen-activated protein (MAP) kinase p38 and its upstream activator MAP kinase kinase 6 are involved in the activation of signal transducer and activator of transcription by hyperosmolarity. J Biol Chem 274:30222-30227.
8. Bordey A, Lyons SA, Hablitz JJ, Sontheimer H. 2001. Electrophysiological characteristics of reactive astrocytes in experimental cortical dysplasia. J Neurophysiol 85:1719-1731.
9. Chen Y, Swanson RA. 2003. Astrocytes and brain injury. J Cereb Blood Flow Metab 23:137-149.
10. Chneiweiss H, Glowinski J, Premont J. 1988. Mu and delta opiate receptors coupled negatively to adenylate cyclase on embryonic neurons from the mouse striatum in primary cultures. J Neurosci 8:3376-3382.
11. Contreras JE, Sanchez HA, Eugenin EA, Speidel D, Theis M, Willecke K, Bukauskas FF, Bennett MV, Saez JC. 2002. Metabolic inhibition induces opening of unapposed connexin 43 gap junction hemichannels and reduces gap junctional communication in cortical astrocytes in culture. Proc Natl Acad Sci USA 99:495-500.
12. Cotrina ML, Kang J, Lin JH, Bueno E, Hansen TW, He L, Liu Y, Nedergaard M. 1998. Astrocytic gap junctions remain open during ischemic conditions. J Neurosci 18:2520-2537.
13. + and PYK2/Cakbeta, two related tyrosine kinases, in rat hippocampal slices: effects of LPA, carbachol, depolarization and hyperosmolarity. Eur J Neurosci 10:1667-1675.
14. Dermietzel R, Hertberg EL, Kessler JA, Spray DC. 1991. Gap junctions between cultured astrocytes: immunocytochemical, molecular, and electrophysiological analysis. J Neurosci 11:1421-1432.
15. Doble BW, Ping P, Kardami E. 2000. The epsilon subtype of protein kinase C is required for cardiomyocyte connexin-43 phosphorylation. Circ Res 86:293-301.
16. Dunn SL, Young EA, Hall MD, McNulty S. 2002. Activation of astrocyte intracellular signaling pathways by interleukin-1 in rat primary striatal cultures. Glia 37:31-42.
17. Duzgun SA, Rasque H, Kito H, Azuma N, Li W, Basson MD, Gahtan V, Dudrick SJ, Sumpio BE. 2000. Mitogen-activated protein phosphorylation in endothelial cells exposed to hyperosmolar conditions. J Cell Biochem 76:567-571.
18. el-Fouly MH, Trosko JE, Chang CC. 1987. Scrape-loading and dye transfer. A rapid and simple technique to study gap junctional intercellular communication. Exp Cell Res 168:422-430.
19. Fischer G, Kettenmann H. 1985. Cultured astrocytes form a syncytium after maturation. Exp Cell Res 159:273-279.
20. Garrels JI. 1979. Two dimensional gel electrophoresis and computer analysis of proteins synthesized by clonal cell lines. J Biol Chem 254:7961-7977.
21. Giaume C, McCarthy KD. 1996. Control of gap-junctional communication in astrocytic networks. Trends Neurosci 19:319-325.
22. Giaume C, Venance L. 1998. Intercellular calcium signaling and gap junctional communication in astrocytes. Glia 24:50-64.
23. Giaume C, Marin P, Cordier J, Glowinski J, Premont J. 1991. Adrenergic regulation of intercellular communications between cultured striatal astrocytes from the mouse. Proc Natl Acad Sci USA 88:5577-5581.
24. Giepmans BN, Verlaan I, Moolenaar WH. 2001a. Connexin-43 interactions with ZO-1 and alpha- and beta-tubulin. Cell Commun Adhes 8:219-223.
25. Giepmans BN, Hengeveld T, Postma FR, Moolenaar WH. 2001b. Interaction of c-Src with gap junction protein connexin-43. Role in the regulation of cell-cell communication. J Biol Chem 276:8544-8549.
26. Giepmans BN, Verlaan I, Hengeveld T, Janssen H, Calafat J, Falk MM, Moolenaar WH. 2001c. Gap junction protein connexin-43 interacts directly with microtubules. Curr Biol 11:1364-1368.
27. Irving EA, Barone FC, Reith AD, Hadingham SJ, Parsons AA. 2000. Differential activation of MAPK/ERK and p38/SAPK in neurones and glia following focal cerebral ischaemia in the rat. Brain Res Mol Brain Res 77:65-75.
28. John GR, Scemes E, Suadicani SO, Liu JS, Charles PC, Lee SC, Spray DC, Brosnan CF. 1999. IL-1beta differentially regulates calcium wave propagation between primary human fetal astrocytes via pathways involving P2 receptors and gap junction channels. Proc Natl Acad Sci USA 96:11613-11618.
29. Kanemitsu MY, Loo LW, Simon S, Lau AF, Eckhart W. 1997. Tyrosine phosphorylation of connexin 43 by v-Src is mediated by SH2 and SH3 domain interactions. J Biol Chem 272:22824-22831.
30. Kanke T, Macfarlane SR, Seatter MJ, Davenport E, Paul A, McKenzie RC, Plevin R. 2001. Proteinase-activated receptor-2-mediated activation of stress-activated protein kinases and inhibitory kappa B kinases in NCTC 2544 keratinocytes. J Biol Chem 276:31657-31666.
31. Kettenmann H, Orkand RK, Schachner M. 1983. Coupling among identified cells in mammalian nervous system cultures. J Neurosci 3:506-516.
32. Kumar S, McDonnell PC, Gum RJ, Hand AT, Lee JC, Young PR. 1997. Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun 235:533-538.
33. Lampe PD, Lau AF. 2000. Regulation of gap junctions by phosphorylation of connexins. Arch Biochem Biophys 384:205-215.
34. Lau AF, Kanemitsu MY, Kurata WE, Danesh S, Boynton AL. 1992. Epidermal growth factor disrupts gap-junctional communication and induces phosphorylation of connexin43 on serine. Mol Biol Cell 3:865-874.
35. Lin JH, Weigel H, Cotrina ML, Liu S, Bueno E, Hansen AJ, Hansen TW, Goldman S, Nedergaard M. 1998. Gap-junction-mediated propagation and amplification of cell injury. Nat Neurosci 1:494-500.
36. Maher P. 2001. How protein kinase C activation protects nerve cells from oxidative stress-induced cell death. J Neurosci 21:2929-2938.
37. McLaughlin MM, Kumar S, McDonnell PC, Van Horn S, Lee JC, Livi GP, Young PR. 1996. Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase. J Biol Chem 271:8488-8492.
38. Menegoz M, Lau LF, Herve D, Huganir RL, Girault JA. 1995. Tyrosine phosphorylation of NMDA receptor in rat striatum: effects of 6-OH-dopamine lesions. NeuroReport 7:125-128.
39. Mesnil M, Yamasaki H. 2000. Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. Cancer Res 60:3989-3999.
40. Nagy JI, Li WE. 2000. A brain slice model for in vitro analyses of astrocytic gap junction and connexin43 regulation: actions of ischemia, glutamate and elevated potassium. Eur J Neurosci 12:4567-4572.
41. Pandey P, Avraham S, Kumar S, Nakazawa A, Place A, Ghanem L, Rana A, Kumar V, Majumder PK, Avraham H, Davis RJ, Kharbanda S. 1999. Activation of p38 mitogen-activated protein kinase by PYK2/related adhesion focal tyrosine kinase-dependent mechanism. J Biol Chem 274:10140-10144.
42. Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D, Hunt T, Nebreda AR. 1994. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78:1027-1037.
43. Saez JC, Berthoud VM, Moreno AP, Spray DC. 1993. Gap junctions. Multiplicity of controls in differentiated and undifferentiated cells and possible functional implications. Adv Second Messenger Phosphoprotein Res 27:163-198.
44. Schubert AL, Schubert W, Spray DC, Lisanti MP. 2002. Connexin family members target to lipid raft domains and interact with caveolin-1. Biochemistry 41:5754-5764.
45. Siushansian R, Bechberger JF, Cechetto DF, Hachinski VC, Naus CC. 2001. Connexin43 null mutation increases infarct size after stroke. J Comp Neurol 440:387-394.
46. Stumpo DJ, Graff JM, Albert KA, Greengard P, Blackshear PJ. 1989. Molecular cloning, characterization, and expression of a cDNA encoding the "80- to 87-kDa" myristoylated alanine-rich C kinase substrate: a major cellular substrate for protein kinase C. Proc Natl Acad Sci USA 86:4012-4016.
47. 2+-independent mechanism. J Neurochem 74:1249-1256.
48. Warn-Cramer BJ, Lampe PD, Kurata WE, Kanemitsu MY, Loo LW, Eckhart W, Lau AF. 1996. Characterization of the mitogen-activated protein kinase phosphorylation sites on the connexin-43 gap junction protein. J Biol Chem 271:3779-3786.
49. Wilson KP, McCaffrey PG, Hsiao K, Pazhanisamy S, Galullo V, Bemis GW, Fitzgibbon MJ, Caron PR, Murcko MA, Su MS. 1997. The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase. Chem Biol 4:423-431.
50. Yamasaki Y, Matsuura N, Shozuhara H, Onodera H, Itoyama Y, Kogure K. 1995. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 26:676-680.
51. Yashima R, Abe M, Tanaka K, Ueno H, Shitara K, Takenoshita S, Sato Y. 2001. Heterogeneity of the signal transduction pathways for VEGF-induced MAPKs activation in human vascular endothelial cells. J Cell Physiol 188:201-210.
52. Young PR, McLaughlin MM, Kumar S, Kassis S, Doyle ML, McNulty D, Gallagher TF, Fisher S, McDonnell PC, Carr SA, Huddleston MJ, Seibel G, Porter TG, Livi GP, Adams JL, Lee JC. 1997. Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. J Biol Chem 272:12116-12121.